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ABSTRACT 
Gap junctions are transmembrane structures that directly connect the cytoplasm of adjacent 
cells, making intercellular communications possible. It has been shown that the behaviour of 
several tumours Ð such as bone tumours Ð is related to gap junction intercellular 
communications (GJIC). Several methodologies are available for studying GJIC, based on 
measuring different parameters that are useful for multiple applications, such as the study of 
carcinogenesis for example. These methods nevertheless have several limitations. The present 
manuscript describes the setting up of a DEP-based lab-on-a-chip platform for the real-time 
study of Gap Junctional Intercellular Communication between osteosarcoma cells and the 
main cells accessible to their microenvironment. We conclude that using the DEParray 
technology for the GJIC assessment has several advantages comparing to current techniques. 
This methodology is less harmful for cells integrity; cells can be recovered after interaction to 
make further molecular analysis; it is possible to study GJIC in real time; we can promote cell 
interactions using up to five different populations. The setting up of this new methodology 
overcomes several difficulties to perform experiments for solving questions about GJIC 
process that we are not able to do with current technics. 
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INTRODUCTION 
Gap Junctional Intercellular Communication (GJIC) consists of intercellular exchange 
of low molecular weight molecules, and is the only means for direct contact between 
cytoplasms of adjacent animal cells. Gap junctions are specialised plasma membrane 
structures consisting of transmembrane channels, themselves composed of proteins called 
connexins (Cx) that directly link the cytoplasm of adjacent cells, thereby enabling direct 
intercellular communication (Nielsen et al., 2012). The permeability of Gap junction channels 
is finely regulated at the transcriptional and post-translational level via cycles of connexin 
phosphorylation, intracellular Ca
2+
 or H
+
 concentrations, or by hormones (e.g. oestrogen, 
progesterone, androgens...)(Firestone and Kapadia, 2012, Zhang and Shaw, 2013). Many 
physiological roles have been proposed for GJIC such as an major involvement in cellular 
homeostasis and integrator of cellular functions within complex tissues (Vinken et al., 2006); 
an electrical synapses in electrically excitable cells (Meier and Dermietzel, 2006, Vinken et 
al., 2006); a tissue response to hormones (Bian et al., 2015); and a regulatory actors in 
embryonic development (Oyamada et al., 2013). 
 
A critical role in the progression of a variety of tumours has been attributed to gap junction 
intercellular communication (Mesnil et al., 2005, Malekian et al., 2016).  Most studies show 
that GJIC is decreased or absent in cancer cells, independently of the origin of the tissue (e.g. 
glioma, lung, endometrial, breast, cervical or prostate carcinoma), supporting the general 
assumption that GJIC deficiency is associated with the cancerÕs phenotype (Mesnil et al., 
2005, Leithe et al., 2006). It has been hypothesized that this GJIC reduction in cancer cells, 
contributes to dysregulated cellular growth by isolating cells from their neighbors (Aftab et 
al., 2015). Despite the vast majority of neoplastic cells have reduced GJIC compared to their 
non-neoplastic counterparts (Mesnil et al., 2005, Leithe et al., 2006), there are exceptions in 
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that some cancer cells have normal or greater gap junction expression and cell-cell coupling 
(Kapoor et al., 2004, Naus and Laird, 2010). This does not indicate, however, that such cells 
communicate normally. 
	
Several methods have been used successfully to understand the physiology of cell-to-cell 
communications, most of them based on dye transfer such as microinjection, scrape loading, 
gap-fluorescence recovery after photo-bleaching (gap-FRAP), parachute assay, and local 
activation of a molecular fluorescent probe (LAMP). Others consist in measuring electrical 
conductance by dual patch clamp or endogenous compounds transference such as 
radio-labelled nucleotides or intercellular calcium waves (Abbaci et al., 2007). They are 
useful for multiple applications, including the study of carcinogenesis, metabolism, 
embryogenesis, etc., but also present several limitations (i.e. invasive methods that alter cell 
integrity; restrictions to the possibility of carrying out time-lapse experiments; technically 
challenging and time-consuming; or limited number of cells analysed). The present 
manuscript describes a new semi-quantitative methodology using a DEP-based lab-on-a-chip 
platform for the real-time study of Gap junctional intercellular communication that overcomes 
some of the limitations presented by the conventional methods. For the setting up of this new 
methodology, we selected the bone tumour niche which is composed of a very complex 
cellular network with a large variety of cells (e.g. vascular cells, bone cells, immune cells) 
communicating by means of soluble mediators (e.g. cytokines, growth factors) and direct 
intercellular interactions (Krzeszinski and Wan, 2015, Shiozawa et al., 2015, Stains and 
Civitella, 2016). In the study, we performed interactions of osteosarcoma cells with the main 
cells accessible to their microenvironment (osteoblasts, osteocytes, osteoclasts and endothelial 
vascular cells). 
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MATERIALS AND METHODS 
 
Cell cultures  
The human osteosarcoma cell line MNNG/HOS and KHOS were purchased from the 
American Type Culture Collection (ATCC) and maintained in DMEM supplemented with 
10% foetal bovine serum (FBS) and 1% penicillin/streptomycin. Human Vascular Endothelial 
Cells were acquired from the ATCC and cultured in gelatine-coated plates and ECGM2 
supplemented media. The mouse MLOY-4 osteocytic cell line was kindly provided by Dr L. 
Bonewald (University of Missouri, Kansas City, USA). Cells were cultured on 
collagen-coated dishes and maintained in a modified essential medium (α-MEM) 
supplemented with 5% FBS, 5% calf serum (CS), and 1% penicillin and streptomycin. Cells 
were cultured in a humidified 5% CO2/air atmosphere at 37¡C. 
 
Osteoclast differentiation 
CD14
+
 were obtained from peripheral blood mononuclear cells isolated by 
centrifugation over Ficoll gradient from the blood of healthy donors (Etablissement Franais 
du Sang, Nantes, agreement referenced NTS 2000-24, Avenant n¡10). CD14
+
 cells were 
magnetically labelled with CD14 microbeads and positively selected by MACS technology 
(Miltenyi Biotec, Germany). The purity of the cells was assessed by flow cytometry 
(Cytomics FC500; Beckman Coulter, France) and was > 95%. The CD14
+
 were cultured in 
α-MEM medium (Minimum Essential Medium, Lonza, Belgium) supplemented with 10% 
FBS and differentiated toward osteoclasts in the presence of 25 ng/mL of human Macrophage 
Colony Stimulating Factor (and 100 ng/mL of human Receptor Activator of Nuclear Factor 
KappaB Ligand (hRANKL) for 11 days. Multinucleated cells formed with three nuclei and 
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more were counted after TRAP staining to verify osteoclast differentiation (Duplomb et al., 
2008). 
 
Human mesenchymal cells (hMSCs) and osteoblast differentiation 
Bone marrow, harvested by iliac crest aspiration from healthy donors was obtained 
from the ÒEtablissement Franais du SangÓ (Nantes, France) with informed consent and 
ethical approval. Human mesenchymal stem cells (hMSC) were cultured in DMEM 
supplemented with 10% of FBS, 2 ng/ml of basic fibroblast growth factor (bFGF), 100 U/ml 
of penicillin/streptomycin, and 2 mM of L-glutamine (proliferation medium). Adherent cells 
were frozen at passage 2 after characterisation by flow cytometry (CD45
-
, CD34
-
, CD105
+
, 
CD73
+
, and CD90
+
, purity ≥ 99%) prior to further experiments. Two hundred thousand 
hMSCs were seeded in 24-well plates in proliferation medium and allowed to attach and reach 
confluence (this represented day 0 for hMSC osteogenic differentiation). After 3 days, the 
medium was changed without bFGF but supplemented with vitamin D3 (10
-8 
M) and 
dexamethasone (10
-7 
M). Three days later, ascorbic acid (50 ng/ml) and β-glycerophosphate 
(10 mM) were added to allow mineralisation, detected by alizarin red-S staining as described 
previously. Osteoblastic markers were identified at 7 and 21 days by quantitative PCR 
(Duplomb et al., 2008). 
 
Gene silencing  
Knockdown of Cx43 using short hairpin RNA (shRNA) in human KHOS cells was obtained 
by lentiviral cell transduction. Lentiviral particles production was performed using 
MISSION¨ shRNA Plasmid DNA targeting Cx43 [TRCN0000059777 (shCx43.1); 
TRCN0000059776 (shCx43.2) from Sigma-Aldrich)] following the protocols provided with 
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the ViraPower Lentiviral Expression System (Invitrogen).  Cx43 levels after lentiviral cell 
transduction was evaluated by RT-qPCR and Western blot.  
 
Gap Junction Intercellular Communication (GJIC) analysis 
GJIC was determined by the analysis of intercellular dye transfer. Briefly, cells of 
interest were detached from the respective plates with accutase, to minimise cell membrane 
receptors damage, and were divided into ÒacceptorÓ and ÒdonorÓ groups as described in 
Talbot et al. (2013). Acceptor cells were loaded with a DiI solution (Life Technology, 
France), a non-transferable membrane dye, and donor cells were dyed with 
calcein-acetoxymethylester (Calcein-AM, Life Technology, France) for 45 min at room 
temperature. After the incubation period, the cells were washed in PBS to remove excess dye, 
and resuspended in culture media. Then, a mixture of cells (10
4
 cells from each population) 
was prepared and loaded into the DEPArrayª cartridge to follow the dye coupling. Some 
experiments were carried out in the presence of 2 mM ethanol, a conventional inhibitor of 
GJIC (Chiba et al., 1994, Dillon et al., 2013, Mustonen et al., 2005, Noritake, et al., 2015).  
!
DEPArrayª device 
DEPArrayª technology is based on the ability of a non-uniform electric field to 
exert forces on neutral, polarisable particles, such as cells, which are suspended in a 
liquid (Tellez-Gabriel et al., 2016). This electrokinetic principle, called dielectrophoresis 
(DEP), can be used to trap cells in DEP cages by creating an electric field above a subset 
of electrodes in an array that is in counter phase with the electric field of adjacent 
electrodes. When a DEP cage is moved by a change in the electric field pattern, the 
trapped cell moves with it. This DEP technology is combined with high quality 
image-based selection that allowed us to identify, make interact and recover specific 
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individual cells of interest from complex, heterogeneous samples 
(http://www.siliconbiosystems.com)(Figure 1A). 
 
Reverse transcriptionÐ quantitative Polymerase Chain Reaction (RT-qPCR) 
Total RNA was extracted from cultured cells using NucleoSpin¨RNAII (Macherey 
Nagel, Germany). Total RNA was reversed transcribed using the Maxima H Minus First 
Strand cDNA Synthesis kit (ThermoFisher, France).  For the osteoblasts recovered from the 
DEPArrayª, we used the Cell to Ct kit (Ambion, USA) for RNA extraction and RT-PCR 
reaction following the manufacturerÕs instructions. Real-time monitoring of PCR 
amplification of complementary DNA was performed using DNA primers on a CFX96 
real-time PCR detector system (Bio-Rad, France) with SYBR Select master Mix (Life 
technologies, France). Primer sequences are provided in Supplementary Table 1. Master Mix 
buffer Target gene expression was normalised to glyceraldehyde 3-phosphate dehydrogenase 
and β2-microglobuline levels in respective samples as an internal standard, and the 
comparative cycle threshold (Ct) method was used to calculate relative quantification of target 
mRNAs. Each assay was performed in triplicate.  
 
Western Blot 
Cells were lysed in RIPA buffer (Tris pH8 10 mM, EDTA 1mM, NaCl 150 mM, NP40 
1%, SDS 0,1%) containing a cocktail of protease and phosphatase inhibitors (1 mM sodium 
orthovanadate (Na2VO4), 1 mM phenylmethylsulforyl fluoride (PMSF), 10 mM sodium 
fluoride (NaF), 10 mM N-ethylmaleimide (NEM), 2 µg/ml leupeptin and 1 µg/mlpepstatine) 
at 4¡C and sonicated twice for 30s. 50 µg of total protein were then separated by 
SDS-polyacrylamide gel electrophoresis and transferred to Immobilon-P membranes 
(Millipore, Billerica, MA, USA). Membranes were immunoblotted with anti-Connexin43 
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(mouse monoclonal antibody, dilution 1/1000, Sigma) and or anti-β-actin (rabbit polyclonal 
antibody, dilution 1/1000, Sigma) antibodies.  
 
Fluorescence quantification  
We quantify the transference of calcein from the donor cell to the receptor cell using 
ImageJ software (v1.49, NIH). We manually drew an outline around the cell/s of interest 
using circle, polygon free tools, and we measured the following parameters: integrated 
intensity, area and mean gray value. Also we calculated the intensity of fluorescence for the 
background, selecting three different areas adjacent to the cell. The total corrected cellular 
fluorescence (TCCF) = integrated density of selected cell Ð (area of selected cell × mean 
fluorescence of background readings), was calculated (Supplementary Figure 1). Each 
measure was repeated three times independently.  
 
Statistical analysis 
Each investigation was reproduced three times in independent experiments. Results 
were analyzed with the unpaired Mann-Whitney U test using two- tailed p values. Results are 
given as mean+SD and results with p < 0.05 were considered as significant. Statistical 
calculations were performed with the SPSS software (version 21.0; SPSS, Chicago, IL, USA). 
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RESULTS 
Setting-up programmable cell-cell interaction and time-lapse imaging 
We used different human cell lines to set up a protocol to perform cell-cell interactions 
in the DEPArray
TM
 and further analysis of GJIC in a time-dependent manner. Two cell 
populations of interest were labelled with different fluorochroms: DiI and Calcein, red and 
green fluorescent respectively, mixed at 1:1 ratio and injected into the DEPArray
TM
 cartridge. 
Individual movements of cells were manually programmed within the chip in predetermined 
spatial coordinates and afterwards forced cell-cell interaction at different ratios in Calcein-DiI 
stained cells (Figure 1B). To monitor the transference of Calcein to DiI stained cells and then 
to evaluate functional GJIC, time lapse imaging for the capture of fluorescence was 
programmed. 
 
Human osteosarcoma cells communicate by functional gap junctional intercellular 
communications  
We first investigated the intercellular communications established between human 
osteosarcoma (hOS) cells and programmed cell-cell interactions in the DEPArray
TM 
using 
different cell ratios. As shown in Figure 2, the Calcein transfer to DiI stained cells was 
observed from 2 hours after interaction at ratios 1:1 and 1:3 (calcein stained cells: DiI stained 
cells). In both cases the transfer of fluorescence between hOS cells increased in a 
time-dependent manner, and at 6 hours the Calcein was almost totally transferred (67% for 
1:1 ratio and 71% for 1:3 ratio, p<0.01). At 1:2 and 1:4 ratios, similar results were observed 
(data not shown), demonstrating that hOS are thus able to communicate by means of 
functional GIJC. A treatment with ethanol abolished the dye transfer between hOS cells, 
demonstrating the involvement of GJIC in this process (Supplementary Data 2).  
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Functional gap junctional intercellular communications between osteosarcoma cells and 
cells that form the bone tumour microenvironment depends on the differentiation state of 
osteoblastic cells  
The bone microenvironment is a very complex system in which many homotypic or 
heterotypic cell-cell interactions take place. We thus studied the GJIC between human 
osteosarcoma (hOS) cells and the bone cells present in the bone tumour niche such as 
osteoblasts, osteoclasts or osteocytes. To elucidate the GJIC between hOS cells and 
osteoblasts, four independent experiments were performed using osteoblasts at different 
stages of differentiation: undifferentiated mesenchymal stem cells (MSC), and MSC after 7 
and 21 days of differentiation into osteoblasts. As expected, the expression of RUNX2 and 
ALP, which play critical roles in osteoblast differentiation and osteoblastogenesis 
respectively, was directly correlated with the stage of MSC differentiation (Figure 3A). 
Interestingly, establishing functional GJIC between hOS and osteoblasts was dependent on 
the stage of differentiation of the bone cells (Figure 3B-D). Osteoblast precursors (MSC) were 
unable to interact with hOS by means of functional GJIC, as revealed by the absence of 
fluorescence transfer between hOS and this cell line (Figure 3B). Similarly, osteocytes were 
not able to interact with hOS by means of functional GJIC, as revealed by the absence of 
fluorescence transfer between hOS and both cell lines (Supplementary Figure 3). On the 
contrary, Figures 3C and 3D show that hOS cells and osteoblasts at both early and late stages 
of differentiation (7 and 21 days) interacted together through functional GJIC. We did not 
observe any difference in these forms of cell communication in relation to the ratio of 
interacting cells. These observations are correlated with the expression of CX43 which is 
lower in mesenchymal stem cells than in osteoblasts (Figure 3A).  
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Osteoclasts and hOS cells do not communicate by Gap junctions 
Osteoclasts are the second main cellular component that controls bone metabolism. 
We initiated cell-cell interactions between pre-osteoclasts (monocytes CD14
+
) and 
differentiated TRAP
+
 osteoclasts [at 5 and 11 days of RANKL treatment (Figure 4 A-C)]. As 
shown in Figure 4, no transference of Calcein from CD14
+
 monocytes or from osteoclasts to 
hOS cells was observed in any of the experimental conditions used, showing that hOS and 
monocytic lineage do not interact by means of functional GJIC. 
 
Demonstration of functional Gap Junctional Intercellular Communication between human 
vascular endothelial cells and osteosarcoma cells 
The vascular system is essential for both tumour progression and tumour cell 
extravasation during the metastatic process (Hicklin and Ellis, 2005). In this context, GJIC 
between human vascular endothelial cells (hVEC) and human osteosarcoma cells was 
assessed. Calcein transfer was observed from hVEC to hOS cells after 3 hours of cell 
interaction at different ratios, showing that functional communication had been established 
between both cell types by means of GJIC (Figure 5). 
 
Inhibition of Gap Junctional Intercellular Communication in knockdown CX43 cells 
Cx43 has been described as an essential protein for the formation of Gap junctions 
(Aftab et al., 2015). In order to determine if the transference of Calcein to DiI stained cells 
was linked specifically with the GAP junctions, we carried out cell-cell interactions studies by 
using the DEPArra
yTM
 approach in Cx43 knockdown osteosarcoma cells (Figure 6). 
Osteosarcoma cells transduced with Cx43-shRNA were characterized by a marked decrease 
of Cx43 gene expression as shown by RT-qPCR compared to the control shRNA and the 
parental cell lines (Figure 6A). Western blot analysis revealed that the level of Cx43 protein 
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simultaneously downregulated confirming the Cx43 knockdown efficacy of the shRNA used 
(Figure 6B). Interestingly, in contrast to shRNA control transduced cells in which the dye 
transfer was maintained between osteosarcoma cells (Figure 6C), the calcein transference was 
totally abolished in Cx43-shRNA modified cells (Figure 6D). The knockdown experiments 
demonstrated that the calcein transference between osteosarcoma cells were Cx43 dependent 
and confirmed the results obtained in the presence of a connexin inhibitor (Supplementary 
Figure 2).  
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DISCUSSION 
It is well-known that Gap Junctional Intercellular Communication is related to cancer 
(Cronier et al., 2009), but little data is available concerning the role of GJIC in osteosarcoma, 
specifically with regard to the presence of functional GJIC between tumour cells and the cells 
that make up the bone tumour microenvironment. To study this physiological process, several 
methodologies are available, although they have several limitations (Abbaci et al., 2007). In 
an attempt to better describe the Gap communications established between the different 
components present in the bone microenvironment, for the first time we used a protocol based 
on di-electrophoretic forces. The use of DEPArray
TM
 technology for assessing GJIC has 
several advantages in relation to current techniques in use: i) this technique is not an invasive 
method and maintains cell integrity; ii) it is possible to recover cells after interaction for 
further analysis; iii) the number of interacting cells can be controlled easily; iv) it is possible 
to programme a time lapse to analyse GJIC in real time; v) the system makes it possible to 
detect up to 5 different fluorochromes, and vi) it is possible to conduct the experiment with a 
minimal quantity of cells and to analyse dye transfer at the Òsingle cellÓ level. Despite all the 
advantages of this methodology, there are nevertheless a certain number of limitations, such 
as: i) the size of the cells studied, which should be between 7 and 40 µm; ii) the experimental 
conditions, such as temperature (all the experiments are carried out at 25¼C) or media, are 
quite restrictive with a potential impact of their viscosity on cell mobility. Indeed, the cell 
mobility is directly related to the viscosity of their environment and must be between 1 and 
1.5 cP; iii) the absence of any extracellular matrix may have an impact on the Gap junction 
formed (Imbeault et al, 2009).  
The DEPArrayª technology allowed us to define a dynamic vision of the GJIC 
established between the different cell types that make up the bone tumour microenvironment 
(Figure 7). The inhibition of Calcein transference observed in the presence of a connexin 
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inhibitor and in Cx43-knockdown osteosarcoma cells confirmed the key role played by the 
Cx43 in GJIC process (Aftab et al., 2015). Our assessment of functional GJIC in HOS cells 
done by DEPArrayª microfluidic approach is in agreement with a recent new high 
throughput screening proposed by Lee et al. (2015) in the cell line. Interestingly, this 
manuscript did not alter cell viability and we cultured pools of cells and single cells after 
parachute assay and after recovery step by the DEPArray
TM
 (Data not shown). Similarly, the 
GJIC between tumour cells and vascular endothelial cells demonstrated in this manuscript 
was in agreement in the literature. The close contact between invasive cancer cells and 
endothelial cells is a preliminary step for metastasis. This step is necessary for the 
extravasation of tumour cells into the bloodstream. A complex process of recognition occurs 
between the two cell types during this crucial phase (Pollmann et al., 2005, Saito-Katsuragi et 
al. 2007). In line with several studies (Gramsch et al. 2001, Matemba et al. 2006), we found 
an increase in Cx43 expression in the differentiated osteoblasts. This may explain why we 
observed GJIC between hOS cells and differentiated osteoblasts at either 7 or 21 days, 
whereas no cell-cell communication was observed between osteoblast precursors (MSC) and 
tumour cells. In addition, it is well-known that the formation of Gap junctions is necessary for 
the maturation process of osteoblasts (Lloyd and Donahue, 2010). In addition, it has 
previously been demonstrated that human precursors and mature osteoclasts express Cx43, 
which appears to be related to osteoclastogenesis (Matemba et al., 2006, Schilling et al., 2008, 
Stains and Civitella, 2016). One crucial question is now to determine whether or not 
osteoclasts/osteoblasts are able to communicate together using GJIC. The present data are not 
in favour of this hypothesis because we did not observe GJIC between human osteoclasts and 
hOS cells using the DEPArrayª approach. However, the formation of functional GJIC 
between these two cell types in humans cannot be totally excluded in adherent cell conditions. 
Future research will be directed towards increasing our knowledge in this area. The 
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DEPArrayª technology makes it possible to manipulate up to 5 different populations in the 
same experiment (5 different fluorochromes). This can be used to perform cell-cell 
interactions with more than two populations, as a means of determining to what extent such 
multiple interactions have an impact on GJIC functionality. As this technique makes it 
possible to recover cells after homotypic and heterotypic interactions, the idea is to analyse 
the mRNA expression of previously determined markers, and to compare expression in 
non-interacting cells. The use of drugs targeting Gap junctions has important implications in 
GJIC which can in turn have a direct impact on the progression of cancer. This methodology 
provides a new means of studying the effect of these drugs with greater accuracy. 
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FIGURE LEGENDS 
	
Figure 1: Schematic representation of the DEPArray
TM
 experiment to study functional 
Gap Junctional Intercellular Communication. A) DEPArrayª technology is based on 
dielectrophoretic forces to trap cells in DEP cages. When a DEP cage is moved by a change in 
the electric field pattern, the trapped cell moves with it. B) Different steps for cell-cell 
interaction in the DEPArray. Heterogeneous distribution in the cartridge of two different 
stained cell populations (Calcein and DiI) (1). Program different cell-cell interactions, moving 
cells to different spatial coordinates (2). Force cells to interact (3). Monitor transference of 
Calcein to DiI cells by taking different time lapse pictures (4). 
	
Figure 2: Time-lapse imaging of the homotypic Gap Junctional Intercellular 
Communication between human osteosarcoma cells. Calcein transfer to DiI stained cells 
was observed from 4 hours after interaction at a ratio of 1:1 and from 2 hours after promoting 
cell-cell interactions at a ratio of 1:3. The yellow circles indicate the cells on which the 
intensity of fluorescence was measured. * p<0.01. 
	
Figure 3: The establishment of Gap Junctional Intercellular Communication between 
human osteosarcoma cells and osteoblasts is linked to the cell differentiation stage of the 
mesenchymal stem cells (MSC). A) Determination of ALP and RUNX mRNA expression by 
RTqPCR. (B-D) Images and calcein tranfer quantification from MSC, osteoblasts at 7 and 21 
days of differentiation to hOS cells, respectively. We capture images at 0, 2, 4 and 6 hours 
after interaction. The yellow circles indicate the cells on which the intensity of fluorescence 
was measured. * p<0.05. 
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Figure 4: Gap Junctional Intercellular Communication between human osteosarcoma 
cells and osteoclasts. (A-C) Analysis of calcein transfer from CD14
+
 monocytes, osteoclasts 
at 5 and 11 days of RANKL treatment (upper) and the corresponding TRAP image (bottom) 
analysis. The yellow circles indicate the cells on which the intensity of fluorescence was 
measured. 
!
Figure 5: Gap Junctional Intercellular Communication between human osteosarcoma 
cells and vascular endothelial cells.  Calcein transference from hVEC to hOS cells was 
observed from 3 hours at different ratios 1:1 (A) and 1:2 (B). The yellow circles indicate the 
cells on which the intensity of fluorescence was measured. * p<0.01. 
 
Figure 6: DEPArray
TM
 imaging of dye transfer in Cx43-shRNA knockdown 
osteosarcoma cells. (A) Cx43 gene expression determined by RT-qPCR, in KHOS parental 
cell line (P), transduced with two different Cx43-shRNA (shCx43.1 And shCx43.2) and two 
concentrations of lentiviral particles (a and b) or with a scramble shRNA (shCT). (B) Cx43 
expression was analysed at the protein level by Western blot. Both Cx43-shRNA used 
decreased markedly the protein expression of the non-phosphorylated (P0) and 
phosphorylated forms of Cx43. (C) Calcein transfer to DiI stained cells was observed from 3 
hours after interaction at a ratio of 1:1 in cells transduced with shControl as observed by the 
DEPArray
TM
 assay. (D) No transfer of Calcein to DiI stained cells was observed in Cx43 
knockdown osteosarcoma cells. The yellow circles indicate the cells on which the intensity of 
fluorescence was measured. ** p<0.01. 
 
Figure 7: Gap Junction Intercellular Communications in the bone tumour niche. 
Communications through Gap junctions were established in a homotypic fashion between 
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osteosarcoma cells, and in a heterotypic manner between osteosarcoma cells, pre-osteoblasts 
and differentiated osteoblasts. Osteosarcoma cells did not establish GJIC with either 
osteoclasts or pre-osteoblasts. Dashed lines indicate the establishment (green) and the absence 
(red) of GJIC.   
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Supplementary Figure 1: Example of the method of fluorescence intensity 
measurement within cells !
Total corrected cellular fluorescence (TCCF) = integrated density of selected cell Ð (area 
of selected cell ! mean fluorescence of background readings) 
Selected cell 
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Supplementary Figure 2 : Time-lapse imaging of the homotypic Gap 
Junctional Intercellular Communication between human MNNG/HOS 
osteosarcoma cells treated with 2mM ethanol.  Cells where treated with 
ethanol during cell cell interaction time and no transfer of Calcein to DiI 
stained cells was observed. The yellow circles indicate the cells on which 
the intensity of fluorescence was measured . 
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Supplementary Figure 3. Time-lapse imaging of the homotypic Gap 
Junctional Intercellular Communication between osteocytes and hOS. 
The transference of Calcein between osteocytes (MLOY-4 cells) and hOS 
was not observed. The yellow circle indicates the cell on which the 
intensity of fluorescence was measured in this example. The yellow circles 
indicates the cells on which the intensity of fluorescence was measured. 
Time (h) 
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Supplementary Table 1: qPCR primers 	
	Gene Primer Sequences 
Human ALP (Alkaline 
Phosphatase) 
Fw       5Õ-AACACCACCCAGGGGAAC-3Õ 
Rev      5Õ-GGTCACAATGCCCACAGATT-3Õ 
Human Cx43 (Connexin 43) Fw       5Õ-GCCTGAACTTGCCTTTTCAT-3Õ  
Rev      5Õ-CTCCAGTCACCCATGTTGC-3Õ 
Human GAPDH 
(Glyceraldehyde 3-
phosphate dehydrogenase) 
Fw       5Õ-TGGGTGTGAACCATGAGAAGTATG-3Õ 
Rev      5Õ-GGTGCAGGAGGCATTGCT-3Õ 
Human RUNX2 Fw      5Õ-GCCTAGGCGCATTTCAGA-3Õ 
Rev     5Õ-GCTCTTCTTACTGAGAGTGGAAGG-3Õ 
Human β2-microglobulin Fw      5′- TTCTGGCCTGGAGGCTATC-3′ 
Rv      5′- TCAGGAAATTTGACTTTCCATTC-3′ 
